NCT06259123View on ClinicalTrials.gov

Neoadjuvant PSMA-RLT in Oligometastatic PCa

PHASE2RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

January 31, 2027

Study Completion Date

June 30, 2027

Conditions
Prostate Cancer
Interventions
DRUG

[177Lu]Lu-PSMA I&T

2 cycles of 5 GBq \[177Lu\]Lu-PSMA I\&T at 6-week intervals prior radical prostatectomy for patients with oligometastatic prostate cancer

Trial Locations (1)

1090

RECRUITING

Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER